MedTrace Logo

Sample Size Definition in Cochrane Hepato-Biliary Trials

NCT01604720 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2015-01-14

No results posted yet for this study

Summary

Sample size definition provides important information, allowing the groundwork for transparent reporting. The sample predefinition allows the trial to be large enough to be able to address the question that is being asked.

The aim of the present study is to assess, in all the randomized controlled trials (RCT) included in the Cochrane Hepato-Biliary Group (CHBG) systematic reviews, the quality of reporting sample size the accuracy of the calculations, the accuracy of the a priori assumptions and the effect on the agreement with pooled results in meta-analyses.

Conditions

  • Definition of Sample Size in Randomized Clinical Trial Assessing Liver Disease

Sponsors & Collaborators

  • Azienda Ospedaliera di Lecco

    lead OTHER

Principal Investigators

  • agostino colli, MD · AO provincia di lecco

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2015-12-31
Completion
2016-04-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01604720 on ClinicalTrials.gov